South America’s most advanced Cannabis Extraction Equipment to be installed outside Bogota, Colombia.


Ryan Allway

February 16th, 2022

News, Top News


BOGOTA, Feb 16, 2022 /PRNewswire/ — CannabCo Pharmaceutical Corp. Colombia S.A.S. (CannabCo Colombia), a Colombia-based cannabis cultivator and manufacturer of medical cannabis products, is pleased to announce the procurement of an enhanced integrated extraction platform to be deployed in their Colombian extraction facility.

 

The equipment to be installed in CannabCo Colombia’s facility, located 45 minutes outside Bogotá, will facilitate the processing of over 100,000 lbs of hemp and cannabis biomass monthly with expandability to over 500,000 lbs as needed.  While the sheer volume of the system makes it one of the most capable extraction processing centers in South America, the true value of the production line is the ability to inline process and “winterize” the extracted oil product with no human intervention.

 


Above: Factory acceptance testing of South America’s most advanced cannabis extraction equipment.

“One of the most tedious, time consuming, and ultimately costly tasks is that of winterization”, said CannabCo Colombia’s Chief Business Development Officer Phillip Chen.  “By utilizing a customized in-line process, we greatly increase productivity and decrease costs associated with the extraction process”.  Mr. Chen further mentions that the lack of human intervention also decreases the risk of contamination and increases overall product purity.

 

Winterizing involves the removal of fats, lipids, waxes, chlorophyll and other undesirables from bulk cannabis oil prior to distillation.  The most common winterization method is taking the oil and dissolving it in sub-zero ethanol at -20 to -80C.  This removes the undesirable compounds and leaves the processor with a semi-refined product.  The processor then filters and separates the ethanol from the valuable winterized oil which can now be used for various products such as vaporizers or edibles, or further processed to a highly concentrated and purified distillate.  This multi-step process is labour intensive, subjects the operator to harmful solvents and fumes, and can take between 24 to 72 hours to complete.  Overall it adds complexity and significant cost to the process of refining Cannabis.

 

“We simplify the entire extraction process whereby cannabis biomass goes in one end and refined winterized hemp or cannabis oil comes out the other” says Phillip.  “The goal of the company is to always have an eye for increased efficiency, product quality, and cost reduction and we have achieved all these factors with our system”.  The entire batch process takes hours instead of days and is highly efficient.

 

The CannabCo extraction line is being hailed as one of, if not the, most advanced extraction system in South America and will be used to process biomass supplied from the company’s three agricultural projects which boast over two million sq/ft of greenhouse production when completed.  In addition the company has extraction agreements for processing of third party biomass from independent farms in the region.

 

About CannabCo Pharmaceutical Corp. Colombia S.A.S.
CannabCo Colombia is a Colombia based full service cannabis company with cultivation projects in multiple regions across the country. The company’s primary extraction plant is located 30 minutes outside the capital city of Bogotá. The company will process both psychoactive and non-psychoactive cannabis and hemp flower for the production of THC and CBD oil for the medical cannabis market.  The company’s state of the art production facilities will have the capability of producing a wide range of end products to meet emerging market supply requirements for Colombia’s evolving cannabis industry, as well as global export. The facility is pursuing EU GMP status allowing access to the underserviced global pharmaceutical market. The company currently has multiple social projects as part of its ethical standards and is committed to the highest quality production of medical grade cannabis products in the industry. The company is vertically integrated controlling all aspects of cultivation, extraction, product manufacturing, and distribution of its medical products allowing it full control over the high quality of its end products. The company intends to be the largest producer and manufacturer of THC/CBD based products on a global scale utilizing Colombia as its operating base.

 

Forward Looking Statements
This press release may contain certain “forward-looking information” and “forward-looking statements” within the meaning of applicable securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. Forward-looking statements may be identified by  statements containing the words “believes”, “anticipates”, “plans”, “intends”, “will”, “should”, “expects”, “continue”, “estimate”, “forecasts” and other similar expressions. Actual results and developments may differ materially from those contemplated by these statements. Although CannabCo Colombia believes that the expectations reflected in forward-looking statements in this press release are reasonable, there can be no assurance that such statements will prove to be accurate. Future events and results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements in this press release.

 

Contact: Investor Relations

info@cannabco.co
www.cannabco.co

SOURCE CannabCo Pharmaceutical Corp. Colombia S.A.S.

 

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading